ANTI-HBV (Hepatitis B Virus) DRUG

Having chronic hepatitis B increases the risk of developing liver failure, liver cancer or cirrhosis – a condition with permanent liver scars.

If you are infected, taking precautionary measures can help prevent the spread of the virus to others.

Symptoms

The signs and symptoms of hepatitis B go from mild to severe.

Some people, usually young children, may not have symptoms.

Signs and symptoms of hepatitis B can include:

• Abdominal pain
• Black urine
• Fever
• Joint pain
• Loss of appetite
• Nausea and vomiting
• Weakness and fatigue
• Yellowing of your skin and white of your eyes (jaundice)
• Preventive treatment can reduce the risk of infection if you receive treatment within 24 hours of exposure to the virus.

If you think you have any signs or symptoms of hepatitis B, consult your doctor.

Causes

It does not spread by sneezing or coughing.

The most common ways HBV can spread are:

Sexual contact. You can get hepatitis B if you have unprotected sex with an infected person.
Sharing needles. Sharing IV drugs puts you at greater risk of hepatitis B.

Accidental needle sticks. Hepatitis B is a problem for health care workers and anyone who comes in contact with human blood.
Mother to child.

However, a newborn baby can be vaccinated to avoid infection in almost all cases. Talk to your doctor about a hepatitis B test if you are pregnant or want to become pregnant.
Chronic hepatitis B versus chronic hepatitis B

Your immune system is likely to eradicate strong hepatitis B from your body, and you should fully recover within a few months.

Risk factors

Your risk of hepatitis B infection increases if:

Have unprotected sex with as many people as you have sex with or with someone who has HBV
Is it a man who has sex with other men
Stay with someone who has a chronic HBV infection
A baby born to an infected mother
Have a job that exposes human blood
Problems

Cirrhosis (cirrhosis). Inflammation associated with hepatitis B infection can lead to severe liver rupture (cirrhosis), which can impair liver function.
Liver cancer. People with chronic hepatitis B have an increased risk of liver cancer.
Liver failure.

Other situations. People with chronic hepatitis B can develop kidney disease or inflammation of the blood vessels.
Prevention
You cannot get hepatitis B from a vaccine source.

Infants
Unvaccinated children and adolescents at birth
Those who work or live in a center for people with developmental disabilities
People living with a person with hepatitis B
Health workers, emergency workers and other people who come in contact with blood
Anyone with a sexually transmitted disease, including HIV
Men who have sex with men

People who have multiple sexual partners
Sexual partners of a person with hepatitis B
Travelers planning to travel to a global area with a high hepatitis B infection rate
Take steps to prevent HBV
Other ways to reduce the risk of HBV include:

Know the HBV status of any sexual partner.
Use a new latex or polyurethane condom every time you have sex if you do not know health.

CERTIFICATE
HOO-IMM PLUS (A, B, C, D) has teamed up with completely new HOOPATIN, novel, pioneering and transforming ideas from HOOTONE REMEDIES to medical science. It is a safe and effective Indian medicine to help all types of Hepatitis, especially HBV and HCV in terms of level and severity.

HOO-IMM PLUS has teamed up with HOOPATIN to work on our pioneering goal: –
It prevents viral replication and DNA polymerase virus Hepatitis B virus.
Immuno Restorative & Hepato Protectors
Treatment And Prophylaxis For Inactive Diseases.
Encourage and maintain physical activity in the body.
How HOO-IMM PLUS works in combination with HOOPATIN
Hepatitis (B & C):
It inhibits DNA polymerase, an enzyme needed for the hepatitis B virus to reproduce.
To protect Hepato, detoxify the liver from the harmful effects of daily exposure to water and airborne food poisoning.

Inhibition of DNA polymerase virus HBV virus and activity that increases the virus.
It relieves congestion and stress conditions of the liver and regulates gallstones.
It speeds up protein synthesis, thereby stimulating cell regeneration.
It prevents liver cell damage and improves the production of antibodies.
Tones up the functions of vital organs.
Reduce the development of diseases.
Reduce and eliminate the risk of opportunistic infections.
It is rarely resistant to many drugs.
It is safe and free of side effects and contraindications.
Completely free from any harmful ingredients such as lead or steroid.
The patient’s immune system, energy and vitality are restored to enable us to live a healthier life.
It also applies to the following diseases:
Toxic liver / body diseases.
Acute Viral Hepatitis,
Chronic Hepatitis,
Chronic, violent Hepatitis,
Liver cirrhosis; Jaundice
Conversion of Liver Fat

Safety data from animal studies, Steroids & Metal free Certified.
Toxological, Stability Stability Study studies were also successfully conducted from the FDA Approved Lab. These drugs have been shown to be free of Steroids or Heavy Metals.
Also, the State and Public Drug Control Laboratory Maharashtra State, Mumbai, testing and evaluation certificate, demonstrates the safety of drugs in all metals, steroids, chemicals and other harmful ingredients.

A better understanding of the drug and its effectiveness in combating HBV and HCV virus should be evaluated above and conducted studies from any reputable and well-equipped facility.
1) Drug Sensitivity Test to determine the level of drug resistance of HBV and HCV.
2) Invivo Clinical studies to detect general improvement and patient health.
3) RNA viral load / Real-time RT-PCR Measurement tests to assess the rate of viral load reduction in patients in the first month, 2nd month and 3rd month of treatment.
INVIVO STUDIES
In clinical studies of Invivo people, the drug was administered as a treatment for HBV & HCV patients by the HAKH Medical Foundation and the patient’s physical and disease development was properly documented, controlled by routine and all HBV / HCV blood tests performed by Molecular Diagnostic Services in accordance with RR and reports and blood samples are stored for more than 3-5 years.

Clinical trials of the drug have revealed the following improvements in patients:
A 7-8 dose decrease in HBV / HCV virus count within 5-6 weeks of treatment.
The viral load decreased below the available range (> 100) within 5-7 months of treatment.
Gains 4-6 pounds in weight in 2-4 months.
Relief from HBV / HCV symptoms.
Prophylactic to combat opportunistic infections.
Patient treatment for 6-8 months had a negative HCV record with the HCV DNA PCR Antigen Test.

For More Info Please Mail Us: info@hootone.org

Thanks Articleritz.com For Promoting This Post